Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001104659-25-036887
Filing Date
2025-04-21
Accepted
2025-04-21 17:00:05
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G/A  
1 primary_doc.xml SCHEDULE 13G/A 5788
  Complete submission text file 0001104659-25-036887.txt   7620
Mailing Address 125 SOUTH CLARK STREET, SUITE 750 CHICAGO IL 60603
Business Address 125 SOUTH CLARK STREET, SUITE 750 CHICAGO IL 60603 (312) 253-9800
Enfusion, Inc. (Subject) CIK: 0001868912 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G/A | Act: 34 | File No.: 005-93478 | Film No.: 25854097
SIC: 7372 Services-Prepackaged Software
(CF Office: 06 Technology)

Mailing Address C/O ENFUSION, INC. 125 SOUTH CLARK STREET, SUITE 750 CHICAGO IL 60603
Business Address C/O ENFUSION, INC. 125 SOUTH CLARK STREET, SUITE 750 CHICAGO IL 60603 312-253-9800
Malherbe Investments LLC (Filed by) CIK: 0001911630 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G/A